Comparison of Local Anesthetic Infiltration and Different Fascial Plane Blocks in Inguinal Hernia Repair
Comparison of the Effects of Local Anesthetic Infiltration and Different Fascial Plane Blocks on Postoperative Recovery Quality and Pain in Inguinal Hernia Repair
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Gizem Cetinkaya, MD
- Phone Number: 905056439790
- Email: gizem.ctnky@gmail.com
Study Locations
-
-
-
Eskişehir, Turkey (Türkiye), 26040
- Eskisehir Osmangazi University Faculty of Medicine
-
Eskişehir, Turkey (Türkiye), 26040
- Eskisehir Osmangazi Universty
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who will undergo elective unilateral inguinal herniorrhaphy under general anesthesia
- American Society of Anesthesiology (ASA) physical classification I-III
Exclusion Criteria:
- Patients who will undergo laparoscopic surgery
- Previous inguinal hernia repair surgery
- A history of opioid use or pain management
- Coagulopathy or anticoagulant use
- Patients who have difficulty communicating or who are not cooperative
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Group Q
Anterior quadratus lumborum block
|
20 mL of 0.25% bupivacaine will be given
|
|
Active Comparator: Group T
Transversus abdominis plane block
|
20 mL of 0.25% bupivacaine will be given
|
|
Active Comparator: Group L
Local infiltration
|
20 mL of 0.25% bupivacaine will be given
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of recovery assessed by Quality of recovery scale (QoR-15)
Time Frame: Postoperative 24th hour.
|
The 15-item quality of recovery (QoR-15) scale is a questionnaire used to evaluate the postoperative recovery quality of patients in the early postoperative stages.
The QoR-15 score comprises 15 questions that assess 5 recovery domains, namely, physical comfort, physical independence, psychological support, emotional status, and pain.
Each question is scored from 0 to 10 (0 none of the time to 10 all of the time).
|
Postoperative 24th hour.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain assessed by Numerical Rating Scale (NRS)
Time Frame: At the 2nd, 6th, 12th, 24th and 36th hours
|
Postoperative pain levels during rest and movement (from supine to sitting position) will be evaluated by Numerical rating scale (0-no pain; 10-unbearable pain)
|
At the 2nd, 6th, 12th, 24th and 36th hours
|
|
Postoperative chronic pain assessed by Numerical Rating Scale (NRS)
Time Frame: Three months later the operation date
|
Patients will be called by phone and the presence of chronic pain will be questioned with the Numerical Rating Scale (0-no pain; 10-unbearable pain).
|
Three months later the operation date
|
|
Postoperative neuropathic pain assessed by Douleur neuropathic pain (DN4) scale.
Time Frame: Three months later the operation date
|
Patients will be called by phone and the presence of neuropathic pain pain will be questioned with the Douleur neuropathic pain (DN4) scale. The items of the DN4 are scored based on a yes (1 point) /no (0 points) answer. This leads to a score range of 0-10. |
Three months later the operation date
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Gulay Erdogan Kayhan, Prof Dr, Eskisehir Osmangazi University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Postoperative Complications
- Pathologic Processes
- Pathological Conditions, Anatomical
- Hernia
- Hernia, Abdominal
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Pain, Postoperative
- Hernia, Inguinal
- Anesthesia and Analgesia
- Anesthesia, Conduction
- Anesthesia
- Anesthesia, Local
Other Study ID Numbers
Other Study ID Numbers
- ESOGUhernia
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.